Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T16:26:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    0.6%
    Check dated 2026-10-26T15:42:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2, with no change to the study record content.
    Difference
    0.1%
    Check dated 2026-10-19T21:44:34.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T04:14:35.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.7.0 and removes the previous revision v3.6.6 from the visible history, reflecting an update to the record's release version.
    Difference
    0.1%
    Check dated 2026-09-21T22:32:54.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A newer revision entry (v3.6.6) was added to the study record history, while the earlier entry (v3.6.5) was removed, reflecting a small update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-08-31T16:37:00.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.